Hollow calcium phosphate microcarriers for bone regeneration: In vitro osteoproduction and ex vivo mechanical assessment

Bio-Medical Materials and Engineering

Volumn 17, Issue 5, 2007, Pages 277-289

  Santoni, Brandon G ^a,d   Pluhar, G Elizabeth ^b   Motta, Tatiana ^b   Wheeler, Donna L ^c  

^a Engineering Research Center and Hydraulics Laboratory   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c BioSolutions Consulting   (United States)

^d Department of Environmental and Radiological Health Sciences   (United States)

Author keywords

Biomaterials; Biomechanics; Bone morphogenic protein; Bone regeneration; Drug delivery; Mesenchymal stem cell

Indexed keywords

BIOACTIVITY; BIOMATERIALS; BIOMECHANICS; BONE; DRUG DELIVERY; GRAFT COPOLYMERS; GROWTH KINETICS; PHARMACOKINETICS; POROSITY; PROTEINS;

BONE MORPHOGENIC PROTEINS; BONE REGENERATION; MESENCHYMAL STEM CELLS; TRICALCIUM PHOSPHATE;

CALCIUM PHOSPHATE;

ALKALINE PHOSPHATASE; CALCIUM PHOSPHATE; OSTEOGENIC PROTEIN 1;

ANIMAL CELL; ARTICLE; BONE REGENERATION; CELL CULTURE; CELL PROLIFERATION; CHEMICAL COMPOSITION; ELUTION; EX VIVO STUDY; IN VITRO STUDY; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; OSTEOLYSIS; POROSITY; PRIORITY JOURNAL; PROTEIN SECRETION; RAT;

ANIMALS; BONE MORPHOGENETIC PROTEINS; BONE REGENERATION; CALCIUM PHOSPHATES; CAPSULES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; MESENCHYMAL STEM CELLS; OSTEOBLASTS; OSTEOGENESIS; RATS; RATS, INBRED F344; TRANSFORMING GROWTH FACTOR BETA;

EID: 34548449422     PISSN: 09592989     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. V.M. Goldberg and S. Stevenson, Natural history of autografts and allografts, Clin. Orthop. Relat. Res. 225 (1987), 7-16.
2. B.N. Summers and S.M. Eisenstein, Donor site pain from the ilium. A complication of lumbar spine fusion, J. Bone Joint Surg. Br. 71 (1989), 677-680.
3. C.J. Damien and J.R. Parsons, Bone graft and bone graft substitutes: A review of current technology and applications, J. Appl. Biomater. 2 (1991), 187-208.
4. R.R. Pelker, G.E. Friedlaender and T.C. Markham, Biomechanical properties of bone allografts, Clin. Orthop. Relat. Res. 174 (1983), 54-57.
5. K.G. Heiple, S.W. Chase and C.H. Herndon, A comparative study of the healing process following different types of bone transplantation, J. Bone Joint Surg. Am. 45 (1963), 1593-1616.
6. C. Delloye, M. Verhelpen, J. d'Hemricourt, B. Govaerts and R. Bourgois, Morphometric and physical investigations of segmental cortical bone autografts and allografts in canine ulnar defects, Clin. Orthop. Relat. Res. 282 (1992), 273-292.
7. W.F. Enneking, D.A. Campanacci, Retrieved human allografts: A clinicopathological study, J. Bone Joint Surg. Am. 83-A(7) (2001), 971-986.
8. M. Kanayama, T. Hashimoto, K. Shigenobu, S. Yamane, T.W. Bauer and D. Togawa, A prospective randomized study of posterolateral lumbar fusion using osteogenic protein-1 (OP-1) versus local autograft with ceramic bone substitute: Emphasis of surgical exploration and histologic assessment, Spine 31 (2006), 1067-1074.
9. M.I. Alam, I. Asahina, K. Ohmamiuda, K. Takahashi, S. Yokota and S. Enomoto, Evaluation of ceramics composed of different hydroxyapatite to tricalcium phosphate ratios as carriers for rhBMP-2, Biomaterials 22 (2001), 1643-1651.
10. S.D. Cook and D.C. Rueger, Osteogenic protein-1: Biology and applications, Clin. Orthop. Relat. Res. 324 (1996), 29-38.
11. K. Hanada, J.E. Dennis and A.I. Caplan, Stimulatory effects of basic fibroblast growth factor and bone morphogenetic protein-2 on osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells, J. Bone Miner. Res. 12 (1997), 1606-1614.
12. G.E. Pluhar, A.S. Turner, A.R. Pierce, C.A. Toth and D.L. Wheeler, A comparison of two biomaterial carriers for osteogenic protein-1 (BMP-7) in an ovine critical defect model, J. Bone Joint Surg. Br. 88 (2006), 960-966.
13. G.E. Friedlaender, Osteogenic protein-1 in treatment of tibial nonunions: Current status, Surg. Technol. Int. 13 (2004), 249-252.
14. M. Pecina, L.R. Giltaij and S. Vukicevic, Orthopaedic applications of osteogenic protein-1 (BMP-7), Int. Orthop. 25 (2001), 203-208.
15. R. Dimitriou, Z. Dahabreh, E. Katsoulis, S.J. Matthews, T. Branfoot and P.V. Giannoudis, Application of recombinant BMP-7 on persistent upper and lower limb non-unions, Injury 36 (Suppl. 4) (2005), S51-S59.
16. J.M. Wozney, Bone morphogenetic proteins, Prog. Growth Factor Res. 1 (1989), 267-280.
17. K. Kurashina, H. Kurita, Q. Wu, A. Ohtsuka and H. Kobayashi, Ectopic osteogenesis with biphasic ceramics of hydroxyapatite and tricalcium phosphate in rabbits, Biomaterials 23 (2002), 407-412.
18. K. Takaoka, H. Nakahara, H. Yoshikawa, K. Masuhara, T. Tsuda and K. Ono, Ectopic bone induction on and in porous hydroxyapatite combined with collagen and bone morphogenetic protein, Clin. Orthop. Relat. Res. 234 (1988), 250-254.
19. M. Itokazu, T. Sugiyama, T. Ohno, E. Wada and Y. Katagiri, Development of porous apatite ceramic for local delivery of chemotherapeutic agents, J. Biomed. Mater. Res. 39 (1998), 536-538.
20. P. Habibovic, H. Yuan, M. van den Doel, T.M. Sees, C.A. van Blitterswijk and K. de Groot, Relevance of osteoinductive biomaterials in critical-sized orthotopic defect, J. Orthop. Res. 24 (2006), 867-876.
21. M.R. Urist, Y.K. Huo, A.G. Brownell, W.M. Hohl, J. Buyske, A. Lietze, P. Tempst, M. Hunkapiller and R.J. DeLange, Purification of bovine bone morphogenetic protein by hydroxyapatite chromatography, Proc. Natl. Acad. Sci. USA 81 (1984), 371-375.
22. Y. Zhang and M. Zhang, Three-dimensional macroporous calcium phosphate bioceramics with nested chitosan sponges for load-bearing bone implants, J. Biomed. Mater. Res. 61 (2002), 1-8.
23. R.K. Korhonen, M.S. Laasanen, J. Toyras, J. Rieppo, J. Hirvonen, H.J. Helminen and J.S. Jurvelin, Comparison of the equilibrium response of articular cartilage in unconfined compression, confined compression and indentation, J. Biomech. 35 (2002), 903-909.
24. A.J. Schoutens, J. Artlet and J.W.M. Gardeniers, Haemodynamics of bone healing in a model stable fracture, in: Bone Circulation and Vascularization in Normal and Pathological Conditions, S.P.F. Hughes, ed., Plenum Press, New York, 1993, pp. 121-128.
25. M. Brookes and W.J. Revell, Blood Supply of Bone: Scientific Aspects, Butterworth & Co., London, 1971.
26. R.S. Taichman and S.G. Emerson, Human osteosarcoma cell lines MG-63 and SaOS-2 produce G-CSF and GM-CSF: identification and partial characterization of cell-associated isoforms, Exp. Hematol. 24 (1996), 509-517.
27. D.P. Lennon, S.E. Haynesworth, R.G. Young, J.E. Dennis and A.I. Caplan, A chemically defined medium supports in vitro proliferation and maintains the osteochondral potential of rat marrow-derived mesenchymal stem cells, Exp. Cell Res. 219 (1995), 211-222.
28. J.E. Dennis, S.E. Haynesworth, R.G. Young and A.I. Caplan, Osteogenesis in marrow-derived mesenchymal cell porous ceramic composites transplanted subcutaneously: Effect of fibronectin and laminin on cell retention and rate of osteogenic expression, Cell Transplant. 1 (1992), 23-32.
29. P. Cassiede, J.E. Dennis, F. Ma and A.I. Caplan, Osteochondrogenic potential of marrow mesenchymal progenitor cells exposed to TGF-beta 1 or PDGF-BB as assayed in vivo and in vitro, J. Bone Miner. Res. 11 (1996), 1264-1273.
30. T.K. Sampath, J.C. Maliakal, P.V. Hauschka, W.K. Jones, H. Sasak, R.F. Tucker, K.H. White, J.E. Coughlin, M.M. Tucker, R.H. Pang et al., Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro, J. Biol. Chem. 267 (1992), 20352-20362.
31. C. Maniatopoulos, J. Sodek and A.H. Melcher, Bone formation in vitro by stromal cells obtained from bone marrow of young adult rats, Cell & Tissue Res. 254 (1988), 317-330.
32. I. Asahina, T.K. Sampath and P.V. Hauschka, Human osteogenic protein-1 induces chondroblastic, osteoblastic, and/or adipocytic differentiation of clonal murine target cells, Exp. Cell. Res. 222 (1996), 38-47.
33. G. Westergren-Thorsson, P.O. Onnervik, L.A. Fransson and A. Malmstrom, Proliferation of cultured fibroblasts is inhibited by L-iduronate-containing glycosaminoglycans, J. Cell Physiol. 147 (1991), 523-530.
34. S.L. Salkeld, L.P. Patron, R.L. Barrack and S.D. Cook, The effect of osteogenic protein-1 on the healing of segmental bone defects treated with autograft or allograft bone, J. Bone Joint Surg. Am. 83-A (2001), 803-816.
35. T.J. Blokhuis, F.C. den Boer, J.A. Bramer, J.M. Jenner, F.C. Bakker, P. Patka and H.J. Haarman, Biomechanical and histological aspects of fracture healing, stimulated with osteogenic protein-1, Biomaterials 22 (2001), 725-730.
36. I. Manjubala, M. Sivakumar, R.V. Sureshkumar and T.P. Sastry, Bioactivity and osseointegration study of calcium phosphate ceramic of different chemical composition, J. Biomed. Mater. Res. 63 (2002), 200-208.
37. M.R. Urist, A. Lietze and E. Dawson, Beta-tricalcium phosphate delivery system for bone morphogenetic protein, Clin. Orthop. Relat. Res. 187 (1984), 277-280.
38. P.K. Zysset, X.E. Guo, C.E. Hoffler, K.E. Moore and S.A. Goldstein, Elastic modulus and hardness of cortical and trabecular bone lamellae measured by nanoindentation in the human femur, J. Biomech. 32 (1999), 1005-1012.
39. S.C. Cowin, Bone Mechanics Handbook, CRC Press, New York, 2001.
40. T.M. Chu, D.G. Orton, S.J. Hollister, S.E. Feinberg and J.W. Halloran, Mechanical and in vivo performance of hydroxyapatite implants with controlled architectures, Biomaterials 23 (2002), 1283-1293.
41. N. Verdonschot, C.T. van Hal, B.W. Schreurs, P. Buma, R. Huiskes and T.J. Slooff, Time-dependent mechanical properties of HA/TCP particles in relation to morsellized bone grafts for use in impaction grafting, J. Biomed. Mater. Res. 58 (2001), 599-604.
42. R.H. Li and J.M. Wozney, Delivering on the promise of bone morphogenetic proteins, Trends Biotechnol. 19 (2001), 255-265.
43. H. Uludag, D. D'Augusta, R. Palmer, G. Timony and J. Wozney, Characterization of rhBMP-2 pharmacokinetics implanted with biomaterial carriers in the rat ectopic model, J. Biomed. Mater. Res. 46 (1999), 193-202.